- Home
- IMMX vs OPTX Comparison
IMMX vs OPTX Comparison
Compare IMMX & OPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- OPTX
- Stock Information
- Founded
- IMMX 2014
- OPTX 1981
- Country
- IMMX United States
- OPTX United States
- Employees
- IMMX N/A
- OPTX N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- OPTX Blank Checks
- Sector
- IMMX Health Care
- OPTX Finance
- Exchange
- IMMX Nasdaq
- OPTX Nasdaq
- Market Cap
- IMMX 50.1M
- OPTX 51.9M
- IPO Year
- IMMX 2021
- OPTX N/A
- Fundamental
- Price
- IMMX $1.61
- OPTX $1.25
- Analyst Decision
- IMMX Strong Buy
- OPTX
- Analyst Count
- IMMX 1
- OPTX 0
- Target Price
- IMMX $7.00
- OPTX N/A
- AVG Volume (30 Days)
- IMMX 48.0K
- OPTX 122.8K
- Earning Date
- IMMX 05-08-2025
- OPTX 05-23-2025
- Dividend Yield
- IMMX N/A
- OPTX N/A
- EPS Growth
- IMMX N/A
- OPTX N/A
- EPS
- IMMX N/A
- OPTX 0.00
- Revenue
- IMMX N/A
- OPTX $29,392,186.00
- Revenue This Year
- IMMX N/A
- OPTX N/A
- Revenue Next Year
- IMMX N/A
- OPTX N/A
- P/E Ratio
- IMMX N/A
- OPTX $750.86
- Revenue Growth
- IMMX N/A
- OPTX 4.36
- 52 Week Low
- IMMX $1.26
- OPTX $0.85
- 52 Week High
- IMMX $3.13
- OPTX $8.39
- Technical
- Relative Strength Index (RSI)
- IMMX 40.16
- OPTX 39.69
- Support Level
- IMMX $1.36
- OPTX $1.20
- Resistance Level
- IMMX $1.90
- OPTX $1.52
- Average True Range (ATR)
- IMMX 0.16
- OPTX 0.10
- MACD
- IMMX -0.01
- OPTX 0.01
- Stochastic Oscillator
- IMMX 35.77
- OPTX 13.51
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About OPTX Syntec Optics Holdings Inc.
Syntec Optics Holdings Inc is vertically integrated from design and component manufacturing for lens system assembly to imaging module integration for system solutions. Making its tools, molding, and nano machining allows close interaction and recut ability, enabling special techniques to hold tolerances to sub-micron levels. It has steadily developed a variety of other complementary manufacturing techniques to provide a wide suite of horizontal capabilities including thin film deposition coatings, glass molding, polymer molding, tool-making, mechanical manufacturing, and nano machining.